Key facts
- It has raised $120K; the latest was Early Stage VC in Aug 2025.
- Notable investors include Peregrine Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Focal Medical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Focal Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Focal Medical Technology
Developer of an invasive medical energy system designed for mapping and focal ablation of prostate cancer. The company's device identifies cancerous lesions of various sizes and destroys them using electric current, enabling medical experts to treat only the cancerous lesion in a manner that does not harm any tissue that is within proximity to the treated area.
- Sector
- Healthcare
- HQ
- Or Yehuda, Israel
- Founded
- 2022
- Employees
- 3
- Website
- focalmd.com/
- Ownership
- Privately Held (backing)
Focal Medical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Focal Medical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Focal Medical Technology in its N-PORT filings yet. We sweep new filings monthly.